6 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 1 | Terminated 1 |
Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism Adrenalectomy, Observation - Subclinical Hypercortisolism, Cushing Syndrome | Phase 2 | Terminated | National Cancer Institute (NCI) | 4 | 2013-11-27 | 2018-06-14 |
| Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia Lapaquistat acetate, Placebo - Hypercholesterolemia | Phase 2 | Terminated | Takeda | 224 | 2007-07-01 | 2012-05-24 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin Betahistine - Hypercholesterolemia | Phase 2 | Terminated | OBEcure Ltd. | 30 | 2007-05-01 | 2007-09-26 |
| Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis atorvastatin, diet - Venous Thromboembolism, Hypercholesterolemia | Phase 2 | Terminated | Università degli Studi dell'Insubria | 10 | 2007-05-01 | 2011-08-19 |
| MK0859 Dose-Ranging Study (0859-003) MK0859 - Hypercholesterolemia, Mixed Hyperlipemia | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 500 | 2006-06-01 | 2015-03-02 |
| Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients 3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 60 | 2006-04-01 | 2013-04-02 |
Adrenal Gland Neoplasms (1) · Adrenal incidentaloma (1) · Cushing Syndrome (1) · Diabetes Mellitus (1) · Dyslipidemias (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type V (1) · Hypertension (1) · Obesity (1) · Osteoporosis (1) · Venous Thromboembolism (1)
Lipid Metabolism Disorders (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Dyslipidemias (5) · Hyperlipidemias (5) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Adrenal Gland Diseases (1) · Adrenocortical Hyperfunction (1) · Body Weight (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Embolism and Thrombosis (1) · Endocrine Gland Neoplasms (1)
1-((1-(3-acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid (1) · 3,5-diiodothyropropionic acid (1) · Adrenalectomy (1) · Atorvastatin (1) · Betahistine (1) · Diet (1) · Observation (1) · Therapeutics (1) · anacetrapib (1)
Johns Hopkins University (1) · Merck Sharp & Dohme LLC (1) · National Cancer Institute (NCI) (1) · OBEcure Ltd. (1) · Takeda (1) · Università degli Studi dell'Insubria (1)
United States (3) · Israel (1) · Italy (1)
Annabelle Rodriguez, MD (1) · Davide Imberti (1) · Dhaval T Patel, M.D. (1) · Gualtiero Palareti (1) · Walter Ageno (1) · Yaffa Beck, Dr. (1)